Case Study: Cue Biopharma achieves clinical-stage readiness and seamless R&D-to-development data flow with Benchling

Cue Biopharma & Benchling Evolving into a clinical-stage organization

Cue Biopharma, a Cambridge, MA–based biopharma company (50–100 employees), engineers novel injectable biologics that selectively modulate T cells to treat cancer, infectious disease, and autoimmune disorders. As the company scaled from research into a clinical-stage organization, it faced non‑standardized data capture across spreadsheets, inconsistent naming and workflows, and growing barriers to communication and handoffs between research and early development teams—creating friction as they brought activities like cell line development in‑house.

Cue implemented Benchling as a unified cloud platform, building a shared data model, templatized notebooks, normalized ontologies, and a request system to automate handoffs and track sample history. The result: over 90% of experiments are recorded with templates, streamlined collaboration between research and development, faster onboarding, better audit readiness and patent workflows, and a robust digital infrastructure that gives Cue a 360° view of scientific progress as it advances toward safer, more efficacious therapies.

Cue Biopharma

Zohra Merazga

Scientist